KOD · Kodiak Sciences Inc
United States · RS rating 98 · As of 2026-11-03
| Price | 98.89 USD |
|---|---|
| 1-day change | +1.3% |
| RS rating (overall / 1M / 3M / 12M) | 98 / 73 / 97 / 98 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 47 / 77 / 42 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +10.3% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +1.5% |
| Market cap (USD) | $2.8B |